Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
The aim of this review is to present current evidence about the efficacy and safety of lesinurad in combination with xanthine oxidase inhibitors (XOIs) in the treatment of hyperuricemia in patients with gout. Gout is the most common inflammatory form of arthritis. It is caused by an elevated concent...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2019-05-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/efficacy-and-safety-of-lesinurad-for-the-treatment-of-hyperuricemia-in-gout |